MD Magazine® Staff

Stay connected and up-to-date in health care news with the Connected Clinician top stories of the week for the week of October 20.

Stay connected and up-to-date in health care news with the Connected Clinician top stories of the week for the week of October 13.

On behalf of Pernix Therapeutics, Dr. Ira Turner (Neurologist/Headache specialist at Island Neurological Associates, Plainview, NY) describes how he approaches treating migraines, including best practices for different age groups and treatment during pregnancy.

The 2017 American Psychiatric Association (APA) Meeting in San Diego, “Prevention Through Partnerships,” helped attendees stay abreast of the rapid changes in the field due to new science, technologies, systems of care, collaborations, and partnerships, while making new connections and renewing old ones. The meeting offered more than 450 educational sessions and courses to expand practitioners’ knowledge, network, and meet certification and licensure requirements.

On behalf of Pernix Therapeutics, Dr. George Nissan (Headache Specialist, North Texas Institute of Neurology and Headache) discusses common migraine triggers and everyday tweaks to help prevent them.

On behalf of Pernix Therapeutics, Dr. Heather McCoy (Nurse Practitioner, Integrative Headache Care, Scottsdale, AZ) describes how she approaches diagnosing migraines, including obtaining a patient’s history, conducting a physical exam, as well as the use of imaging tests.

Readers can expect unprecedented content, such as research developments, articles, and interviews that can help physicians better serve their patients.

On behalf of Pernix Therapeutics, Dr. Bruce Corser (Medical Director, Sleep Management Institute, Cincinnati, OH) describes how he approaches diagnosing and treating insomnia. He discusses cognitive behavioral therapy (CBT), as well as common medications, such as over the counter options, benzodiazepines, non-benzodiazepines among others, to consider with your patients.

On behalf of Pernix Therapeutics, Dr. Damon Raskin (Diplomate of the American Board of Addiction Medicine, Pacific Palisades, Ca) discusses the different types of insomnia, including sleep onset and sleep maintenance insomnia. Dr. Raskin also highlights how age can affect what type of insomnia your patients might be experiencing, as well as treatment goals and examples.

On behalf of Pernix Therapeutics, Dr. Bruce Corser (Medical Director, Sleep Management Institute, Cincinnati, OH) provides an overview of one of the most common sleep disorders, insomnia. Dr. Corser also explains how poor sleep can affect a person’s mood, physical health, work and safety.

Researcher explains the development of Ingrezza for tardive dyskinesia.

Colorectal cancer has long been thought of as an older person’s disease, however, people being diagnosed are getting younger and younger. John L. Marshall, MD, a medical oncologist at Georgetown University in Washington, District of Columbia said that nearly half of his patients with colorectal cancer are under the age of 50.

MD Magazine® and Contagion™ expand Strategic Alliance Partnership with American Academy of HIV Medicine.

At AHA 2016, Poushali Mukherjea, PhD, Bristol-Myers Squibb, discusses 12 abstracts on new real-world data and subanalyses from the pivotal trial ARISTOTLE.

Researchers suggest that family-based cognitive behavioral therapy may be a key factor in treating children with autism spectrum disorder who have problems sleeping.

The CDC's Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, explains how antibiotics can be harmful if they are not used appropriately.

The CDC's Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, discusses how antibiotic prescribing data vary across the United States.

The CDC's Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, discusses antibiotic prescribing data, with an emphasis on outpatient settings.

Watch the CDC's Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, discuss "Get Smart About Antibiotics Week."

Researchers have proposed three key risk factors for transmission and acquisition of carbapenemase-producing carbapenem-resistant Enterobacteriaceae.

Each year, approximately 700,000 people die from drug-resistant bacterial infections. A study by UCLA life scientists could be a major step toward combating drug-resistant infections.

Despite greater scrutiny on this practice in recent years, too many patients with schizophrenia and other serious mental illnesses are discharged from inpatient hospital stays while still taking multidrug regimens of antipsychotic medications.

University of Houston researchers suggest that children who experience inadequate or disrupted sleep are more likely to develop depression and anxiety orders later in life.

Adults diagnosed with bipolar disorder are much more likely than the general population to have suffered emotional, physical, or sexual abuse as children.

Researchers report there is evidence of a correlation between immune recovery and the behavior of a certain subset of gut bacteria in patients with HIV treated with antiretroviral therapy.

Research suggests that lipid screening appears to remain particularly underutilized in adults taking antipsychotic medications, despite improvements in recent years in the use of diabetes screening in this patient population.

Study results show that adults with chronic low back pain are more likely to use illicit drugs—including marijuana, cocaine, heroin, and methamphetamine—than those without chronic low back pain.

The Nell Hodgson Woodruff School of Nursing and Rollins School of Public Health, along with Emory College of Arts and Sciences, and Emory School of Medicine received a $5 million grant from the National Institute of Environmental Health Sciences (NIEHS) and the U.S. Environmental Protection Agency (EPA) to establish a children’s environmental health center.

Mark McClellan, MD, PhD, who served as FDA Commissioner and CMS Administrator, will be the keynote speaker at the fall meeting of the ACO & Emerging Healthcare Delivery Coalition, presented by The American Journal of Managed Care. The meeting will be October 20-21, 2016, in Philadelphia.